According to more recent work [138], panobinostat made a significant difference in inducing complete response in multiple myeloma by combining it with anti-CD38 monoclonal antibody (mAb) daratumumab, which was shown to be effective in multiple myeloma. The gene discussed is CD38; the disease is plasma cell myeloma.